StockGlow

Translational Development Acquisition Corp. (TDACW)

Seeks to buy or merge with a healthcare or biotech company

$1.91-0.09%
Compare TDACW with
StockGlow Score
5
Bearish
BearishBullish
1 year ago+932.4%

The outlook

TDACW trades at $1.91, sitting near its 52-week low with minimal upward room to its high. The StockGlow score of 5/100 reflects a bearish lean. Analyst coverage appears thin or unavailable for this blank-check company.

What’s behind the score

52-week range5% of the way from its 52-week low to high
Market cap
—
52-wk high
$2.00
52-wk low
$1.91
50-day avg
—
200-day avg
—
Trailing P/E
—

Similar stocks

TDACTranslational Development Acquisition Corp.$10.84+0.93%APXTWApex Treasury Corporation$0.41+8.45%TDACUTranslational Development Acquisition Corp.$12.57+8.83%GFUZWGeneral Fusion Group Ltd.$1.66-1.19%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy